Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria La Fe (15)

2024

  1. AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action

    Science advances, Vol. 10, Núm. 41, pp. eadn6525

  2. Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model

    Skeletal muscle, Vol. 14, Núm. 1, pp. 21

  3. Msi2 enhances muscle dysfunction in a myotonic dystrophy type 1 mouse model

    Biomedical Journal, Vol. 47, Núm. 4

  4. Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell models

    Biological Research, Vol. 57, Núm. 1

2023

  1. CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2

    Molecular Therapy - Nucleic Acids, Vol. 31, pp. 324-338

2022

  1. An ultra-sensitive homologous chemiluminescence immunoassay to tackle penicillin allergy

    Analytica Chimica Acta, Vol. 1214

  2. Development of potent tripodal G-quadruplex DNA binders and their efficient delivery to cancer cells by aptamer functionalised liposomes

    Organic and Biomolecular Chemistry, Vol. 21, Núm. 5, pp. 1000-1007

  3. Dystrophinopathy Phenotypes and Modifying Factors in DMD Exon 45–55 Deletion

    Annals of Neurology, Vol. 92, Núm. 5, pp. 793-806

  4. Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency

    Cells, Vol. 11, Núm. 3

2021

  1. A study of the phenotypic variability and disease progression in Laing myopathy through the evaluation of muscle imaging

    European Journal of Neurology, Vol. 28, Núm. 4, pp. 1356-1365

  2. Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 652-667

2019

  1. Beta-blockers: Historical Perspective and Mechanisms of Action

    Revista Espanola de Cardiologia, Vol. 72, Núm. 10, pp. 853-862

  2. Genome wide DNA methylation profiling identifies specific epigenetic features in highrisk cutaneous squamous cell carcinoma

    PLoS ONE, Vol. 14, Núm. 12

2017

  1. Modulation of protein synthesis and degradation maintains proteostasis during yeast growth at different temperatures

    Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1860, Núm. 7, pp. 794-802

2016

  1. Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma

    Journal of Neuroimmunology, Vol. 297, pp. 98-102